A Schedule 13G was filed on November 16, 2026, by American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research, disclosing beneficial ownership positions in the common stock of Sylvamo Corporation as of September 30, 2026.
Key Highlights
- American Century Investment Management, Inc. reported beneficial ownership of 2,116,184 shares, representing 5.3% of Sylvamo Corporation's common stock.
- American Century ETF Trust separately reported beneficial ownership of 2,032,730 shares, representing 5.1% of the class.
- Sole voting and dispositive power: All shares reported by each entity are held with sole voting power and sole dispositive power, with zero shared voting or dispositive power reported.
- American Century Companies, Inc. and Stowers Institute for Medical Research each reported the same aggregate beneficial ownership of 2,116,184 shares, or 5.3%, in their capacity as holding company and control person, respectively.
- Event date: The date of event requiring the filing is stated as September 30, 2026.
- Ordinary course certification: The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
American Century's Reported Holdings in Sylvamo Corporation
According to the Schedule 13G filed with the SEC, four related entities reported beneficial ownership of common stock in Sylvamo Corporation (NYSE:SLVM), headquartered at 6077 Primacy Parkway, Memphis, Tennessee 38119. The triggering event date is listed as September 30, 2026, and the filing was submitted on November 16, 2026. The reporting persons are organized in Delaware and share a principal business address of 4500 Main Street, 9th Floor, Kansas City, Missouri 64111.
The filing discloses that American Century Investment Management, Inc. (ACIM), classified as an investment adviser, holds 2,116,184 shares with sole voting power and sole dispositive power over all such shares, equating to 5.3% of the class. American Century ETF Trust, classified as an investment company, holds 2,032,730 shares on the same sole-power basis, representing 5.1% of the class. American Century Companies, Inc. (ACC), classified as a parent holding company, and Stowers Institute for Medical Research, also classified as a holding company and identified as the controlling entity of ACC, each report the same 2,116,184 aggregate shares and 5.3% figure, reflecting their structural relationship to ACIM.
The filing notes under Item 6 that "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." It further states that no single client advised by ACIM owns more than 5% of the class. ACIM is described as a wholly-owned subsidiary of ACC, registered as an investment adviser under Section 203 of the Investment Advisers Act of 1940. All four entities are co-signatories, with John Pak signing as Senior Vice President on behalf of each.
What Was Disclosed
The Schedule 13G discloses that American Century-affiliated entities, led by American Century Investment Management, Inc. and its parent and control structures, held aggregate beneficial ownership of up to 2,116,184 shares, or 5.3%, of Sylvamo Corporation common stock as of September 30, 2026.




Please wait processing your request...